Skip to content
value.today

NinePoint Medical, Inc.

Total raised
$70 M
3 rounds on record
Latest round
$31 M
Nov 2015
First round on record
Sep 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of NinePoint Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2015$31 MNo. 3$10 to $50 million

NinePoint Medical, Inc.: Raise no. 3, Nov 2015

Investors in this round

3 investors had bought by the notice of Nov 25, 2015: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $41 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher von Jako · Executive Officer, Director
  • Curt J. Weinstein · Director
  • Eric Swanson · Director
  • Henry J. Lee · Director
  • Mark J. Stautberg · Director
  • Mark Levin · Director
  • Russell Hirsch · Director
  • Scott J. Gazelle · Director
  • Thomas J. Miller · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher von Jako, President. Source: SEC Form D, newest notice filed Nov 25, 2015. Read the notice at the SEC.

equitySEC
Mar 2014$35 MNo. 2$10 to $50 million

NinePoint Medical, Inc.: Raise no. 2, Mar 2014

Investors in this round

3 investors had bought by the notice of Mar 18, 2014: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $50 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Carignan · Executive Officer, Director
  • Judith M. Huber · Executive Officer
  • Curt M. Weinstein · Director
  • Eric Swanson · Director
  • Mark Levin · Director
  • Mark M. Stautberg · Director
  • Russell Hirsch · Director
  • Thomas J. Miller · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Charles Carignan, President. Source: SEC Form D, newest notice filed Mar 18, 2014. Read the notice at the SEC.

equitySEC
Sep 2009$5 MNo. 1$2 to $10 million

NinePoint Medical, Inc.: Raise no. 1, Sep 2009

Investors in this round

2 investors had bought by the notice of Oct 8, 2009: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $33 M offered; $28 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A Preferred Stock
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kevin Gillis · Executive Officer
  • Mark Levin · Executive Officer, Director
  • Mitchell Bloom · Executive Officer
  • Russell Hirsch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin Gills, Treasurer. Source: SEC Form D, newest notice filed Oct 8, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • NinePoint Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2015).

    SEC Form D · Nov 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2015

That is all the official record says: NinePoint Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: its website does not allow automated readers.

Investors#

No investor of NinePoint Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 3 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by NinePoint Medical, Inc.
NameRoleNamed in
Christopher von JakoExecutive officerNov 2015
Charles CarignanExecutive officerMar 2014
Judith M. HuberExecutive officerMar 2014
Kevin GillisExecutive officerOct 2009
Mark LevinExecutive officerOct 2009
Mitchell BloomExecutive officerOct 2009
Christopher von JakoDirectorNov 2015
Curt J. WeinsteinDirectorNov 2015
Eric SwansonDirectorNov 2015
Henry J. LeeDirectorNov 2015
Mark J. StautbergDirectorNov 2015
Mark LevinDirectorNov 2015
Russell HirschDirectorNov 2015
Scott J. GazelleDirectorNov 2015
Thomas J. MillerDirectorNov 2015
Charles CarignanDirectorMar 2014
Curt M. WeinsteinDirectorMar 2014
Mark M. StautbergDirectorMar 2014

About

Company in Bedford, United States.